For participating companies/list of participating companies
Social significance of A-TRAIN
- We are carrying out prospective research together with core hospitals in cancer medicine in more than 10 Asian countries, with the aim of promoting cancer genomic medicine.
- We are building a database of clinical information and genetic information of cancer patients in Asia, and are working with pharmaceutical companies regarding the ongoing development of treatments for cancer patients in Asia.
- We are continuing with research while keeping in contact with the regulatory authorities in each country. We are facilitating clinical research in harmony with the regulatory authorities in each country, including when seeking insurance reimbursement for developed devices.
List of participating facilities
Japan
- National Cancer Center Hospital, Japan
Philippines
- St. Luke’s Medical Center, Philippines
Malaysia
- Hospital Umum Sarawak, Malaysia
- University Malaya Medicine Center, Malaysia
- Hospital Kuala Lumpur, Malaysia
- National Cancer Institute, Malaysia
Singapore
- National University Hospital ,Singapore
- National Cancer Centre Singapore, Singapore
Taiwan
- National Taiwan University Hospital, Taiwan
Vietnam
- National Cancer Hospital of Vietnam, Vietnam
- Ho Chi Minh City Oncology Hospital Vietnam
Korea
- Severance Hospital, Yonsei University Health System
List of participating companies
- Guardant Health Asia, Middle East & Africa (AMEA)
- Thermo Fisher Scientific K.K.
- Illumina, Inc
- Chugai Pharmaceutical Co., Ltd.
- Roche Diagnostics K.K.
- intellim Corporation
- SRL, Inc.
- Eurofins